Healthcare -
Biotechnology - NASDAQ - US
$ 0.7556
-7.85 %
$ 4.11 M
Market Cap
-0.01
P/E
ALZN - COST OF REVENUE
Cost of Revenue ALZN - Alzamend Neuro, Inc.
50.7 K
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR